150 related articles for article (PubMed ID: 161096)
1. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
Engleman EG; Benike C; Hoppe RT; Kaplan HS
Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
[No Abstract] [Full Text] [Related]
2. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
3. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
4. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
5. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
[TBL] [Abstract][Full Text] [Related]
6. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
7. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
8. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
Sibbitt WL; Bankhurst AD; Williams RC
J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
[TBL] [Abstract][Full Text] [Related]
9. [Hodgkin's disease--immunological aspects].
Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
[TBL] [Abstract][Full Text] [Related]
10. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
Gupta S
Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
[TBL] [Abstract][Full Text] [Related]
11. [Immunological aspects of Hodgkin's disease].
Bianchini E
Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
[TBL] [Abstract][Full Text] [Related]
12. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
13. Immunology and cellular biology of Hodgkin's disease.
Slivnick DJ; Nawrocki JF; Fisher RI
Hematol Oncol Clin North Am; 1989 Jun; 3(2):205-20. PubMed ID: 2663823
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin-producing suppressor cells in Hodgkin's disease.
Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
[TBL] [Abstract][Full Text] [Related]
15. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
Bockman RS
J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
17. [Abnormal regulation in the production of IL2 in Hodgkin's disease].
Marchiol C; Kaplan C; Chouaib S; Janvier M; Ferme C; Muller JY; Fradelizi D
C R Acad Sci III; 1985; 301(6):283-8. PubMed ID: 3928105
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
[TBL] [Abstract][Full Text] [Related]
19. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
Shiftan TA; Caviles AP; Mendelsohn J
Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]